Humalog pen (insulin lispro) - Eli Lilly
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia (clinicaltrials.gov) - Sep 26, 2026 - P=N/A | N=20 | Active, not recruiting | Sponsor: Centre for Addiction and Mental Health | Recruiting ➔ Active, not recruiting | Trial completion date: Aug 2026 ➔ Dec 2026 | Trial primary completion date: Aug 2026 ➔ Dec 2026 
Enrollment closed • Trial completion date • Trial primary completion date • CNS Disorders • Metabolic Disorders • Psychiatry • Schizophrenia
http://clinicaltrials.gov/ct2/show/NCT05748990
 
Sep 26, 2026
 
Prev Next